Cabaletta Bio, Inc. - stock earnings
CABA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -16.4 million USD | ? USD |
| 2023Q2 | -14.5 million USD | ? USD |
| 2023Q1 | -14.8 million USD | ? USD |
| 2022Q4 | -14.9 million USD | ? USD |
| 2022Q3 | -11.1 million USD | ? USD |
| 2022Q2 | -12.8 million USD | ? USD |
| 2022Q1 | -12.9 million USD | ? USD |
| 2021Q4 | -13.9 million USD | ? USD |
| 2021Q3 | -11.6 million USD | ? USD |
| 2021Q2 | -11.1 million USD | 1 USD |
| 2021Q1 | -9.7 million USD | ? USD |
| 2020Q4 | -9.3 million USD | ? USD |
| 2020Q3 | -8.4 million USD | ? USD |
| 2020Q2 | -8.2 million USD | ? USD |
| 2020Q1 | -7.5 million USD | ? USD |
| 2019Q4 | -5.4 million USD | ? USD |
| 2019Q3 | -4.7 million USD | ? USD |
| 2019Q2 | -3.4 million USD | ? USD |
| 2019Q1 | -3.5 million USD | ? USD |
| 2018Q4 | -1.9 million USD | ? USD |
| 2018Q3 | -9.3 million USD | ? USD |
CABA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -51.8 million USD | ? USD |
| 2021 | -45.5 million USD | ? USD |
| 2020 | -32.5 million USD | ? USD |
| 2019 | -15.1 million USD | ? USD |
| 2018 | -12.2 million USD | ? USD |
| 2017 | -250000 USD | ? USD |
CABA
Price: $12.39
52 week price:
Earnings Per Share: -1.65 USD
P/E Ratio: -14.71
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 489500
Market Capitalization: 907.9 million